Your browser doesn't support javascript.
loading
Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response.
Min, Ahrum; Jang, Hyemin; Kim, Seongyeong; Lee, Kyung-Hun; Kim, Debora Keunyoung; Suh, Koung Jin; Yang, Yaewon; Elvin, Paul; O'Connor, Mark J; Im, Seock-Ah.
Afiliação
  • Min A; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Jang H; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Kim S; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Lee KH; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Kim DK; Cancer Research Institute, Seoul National University, Seoul, Korea.
  • Suh KJ; Biomedical Research Institute, Seoul National University Hospital, Seoul, Korea.
  • Yang Y; Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • Elvin P; Translational Medicine, Seoul National University College of Medicine, Seoul, Korea.
  • O'Connor MJ; Rice University, Houston, Texas.
  • Im SA; Cancer Research Institute, Seoul National University, Seoul, Korea.
Mol Cancer Ther ; 17(12): 2507-2518, 2018 12.
Article em En | MEDLINE | ID: mdl-30232143

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dano ao DNA / Neoplasias da Mama / Antagonistas de Receptores de Andrógenos / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dano ao DNA / Neoplasias da Mama / Antagonistas de Receptores de Andrógenos / Inibidores de Poli(ADP-Ribose) Polimerases Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans Idioma: En Revista: Mol Cancer Ther Assunto da revista: ANTINEOPLASICOS Ano de publicação: 2018 Tipo de documento: Article